Kaleo said today that despite ongoing manufacturing delays reported by epinephrine auto-injector manufacturers, Kaleo’s Auvi-Q device is available via prescription and that the privately-held company has ‘sufficient supply to meet any anticipated demand.’ Kaleo’s epinephrine auto-injector features voice instructions that guide users through the drug-delivery process and an auto-retractable needle system, according to the company. Get […]
Hospira issues nationwide recall for opioid overdose reversal drug
Pfizer’s Hospira unit this week voluntarily recalled two lots of a drug used to reverse the course of an opioid overdose. The company’s naxolone injection, sold in its Carpuject single-use cartridge syringe, was recalled due to the potential presence of embedded and loose particulate matter in the plunger. Get the full story at our sister site, Drug Delivery […]
ICU Medical touts dosing errors study
ICU Medical (NSDQ:ICUI) said today that a multi-hospital study showed improvements in potentially catastrophic dosing errors and drug library compliance when its Plum infusion pumps and Hospira (NYSE:HSP) MedNet safety software were integrated with the hospitals’ electronic medical records. The rate of potentially catastrophic dosing errors fell by 52% after smart-pump EMR integration, the study found, […]
ICU Medical closes $900m buyout of Pfizer’s Hospira infusion pump biz
ICU Medical (NSDQ:ICUI) this week closed its $900 million acquisition of the Hospira infusion pump business from Pfizer (NYSE:PFE), confirming last year’s rumors that the drug giant was looking to sell the business. The deal, which was scaled back from $1 billion last month, called for ICU Medical to offer 3.2 million new shares, or $419.3 million, and $275 million in cash, […]
Pfizer agrees to $100m haircut in Hospira infusion sale to ICU Medical
Pfizer (NYSE:PFE) has agreed to take a $100 million hit on its previously $1 billion sale of its Hospira infusion pump business to ICU Medical (NSDQ:ICUI), bringing in approximately $900 million. The revised deal calls for ICU Medical to offer 3.2 million new shares, or $419.3 million, and $275 million in cash, along with an additional possible […]
Pfizer’s Hospira, Iatric Systems ink infusion pump interoperability deal
Pfizer (NYSE:PFE) said today that its Hospira subsidiary and healthcare IT group Iatric Systems inked a partnership deal to develop interoperability between Hospira’s smart infusion pumps and Iatric’s Accelero Connect integration software. The 2 companies said they are currently piloting smart-pump EMR interoperability at an undisclosed US hospital. “Hospira is proud to partner with Iatric […]
ICU Medical to pay Pfizer $1B for Hospira infusion pump biz
ICU Medical (NSDQ:ICUI) agreed to pay $1 billion in cash and stock for the Hospira infusion pump business owned by Pfizer (NYSE:PFE), confirming rumors that swirled earlier this year that the drug giant was looking to sell the business. The deal calls for ICU Medical to put up $400 million worth of new shares and $600 million in […]
Fresenius, Smiths in the hunt for Pfizer’s $1.5B infusion pump biz
Germany’s Fresenius (NYSE:FMS) and Britain’s Smiths Group (LON:SMIN) have emerged as the final bidders for Pfizer‘s (NYSE:PFE) infusion pump business, inherited via the Big Pharma’s September 2015 purchase of Hospira for $15 billion. The winning bid is expected to be around $1.5 billion, according to Reuters. Private equity firm Pamplona Capital Management was also interested and reportedly made a […]
Hospira launches new LifeCare PCA EMR-linked infusion pump
Hospira said yesterday it is launching the LifeCare PCA 7.0 patient-controlled analgesia infusion pump designed for patient pain management. The company is touting the device as the 1st-PCA infusion pump to offer electronic medical record integration through the use of inegrated bar code identification of prefilled of pharmacy-filled drug vials. “Hospira is proud to deliver the […]
Novartis taps Hospira-sale engineer exec Ball to revive slumping Alcon
Novartis (NYSE:NVS) is looking to revitalize its slumping Alcon eye care division by picking up medical vet Michael Ball, who recently organized Hospira’s $15 billion sale to Pfizer (NYSE:PFE). Ball will replace previous Alcon chief Jeff George, the company announced today. Novartis CEO Joe Jimenez is reportedly putting Ball in control of reviving Alcon. Alcon […]
Stryker CFO Jellison retires, Boehnlein steps up | Personnel Moves
Stryker (NYSE:SYK) said yesterday that CFO and veep William Jellison is retiring, and will be replaced by former medsurg & neurotechnology group CFO Glenn Boehnlein. The Kalamazoo, Mich.-based company said Jellison, who’s been with Styker for 3 years, will pursue positions on boards and devote more time to his family. Jellison will stay on through […]
- 1
- 2
- 3
- …
- 7
- Next Page »
MassDevice Network
@MassDevice
LinkedIn
YouTube